Products and Services
Affinity Chromatography
We support mykotoxin and vitaminanalysis using very effective immunoaffinity columns and ELISAs, and by developing toxin- and detection conjugates.
Primer/Oligonucleotide Synthesis
Long term experience in the field of DNA and RNA primer synthesis guarantees very high quality. We offer various services, fast shipment and ease your budget.
ELISA Technologies
Use our experience in the field of ELISA development, the production of tests and components. Test our innovation “recoveryELISA” for therapeutic drug monitoring.
Biotin-Streptavidin-Binding
Outstanding Biotin binding capacities using our high-tech molecule improve assay performance.
Human Proteases/
Proteins/Enzymes
Human proteases, ELISA & antibodies incl. the former Proteaimmun GmbH products and Services.
Biochemistry services
Extensive customer service in the field of immunochemistry like individual assay compounds or conjugates.
Polystreptavidin R Surface Functionalization Kit
Polystrept R combines the excellent binding capacity with a high chemo and thermo stability.Additional pre-coating serves to improve the outcome and especially for very inert surfaces to ensure high quality coatings with Polystreptavidin R.
Polystreptavidin R provides product consistency and helps to reduce variability in diagnostic assays. Test it; make the comparison of BioTeZ Polystreptavidin R Coating Kit and surface activated beads or other surface activations. Typical applications where Polystreptavidin R is used: IVD assays, isolation and purification of biotinylated molecules, ligand coupling.
The BioTeZ Polystreptavidin R Coating Kit (Product Code: BTCK-MC) is useful for adsorptive coatings on microplates, beads, membranes etc. made of metal, nitrocellulose, ceramic, silicon, glass or plastics like Polystyrene, Polyethylene, Polypropylene, Polycarbonate, Poly(methyl methacrylate) PMMA or Polyamides with “Maximum Biotin Binding Capacity”. More Informations
New method for measuring effect of drugs
BioTeZ starts the project for the development of a companion diagnostic procedure. The aim is to determine the optimal drug dose for each patient to reduce side effects, to achieve the Therapeutic Window and to increase the effectiveness of the active ingredients by optimizing the dosage (Therapeutic Drug Monitoring). The project is being funded on behalf of the State of Berlin through the Program for the Promotion of Research, Innovations and Technologies (Pro FIT) and partially funded by the European Regional Development Fund (ERDF). More Informations
Independent studies show increased thrombosis and pulmonary embolism in COVID-19 patients
Research teams at Hamburg-Eppendorf University Hospital and Beijing Union Medical College Hospital Beijing found that SARS-CoV-2 infections can lead to thrombosis and pulmonary embolism. In addition to atypical pneumonia, which is directly related to the lung tissue affected by SARS-CoV-2,
BioTeZ increased the production capacities of Real-time qPCR probes for COVID-19 research and diagnostics
The recent emergence of the coronavirus SARS-CoV-2 (the virus that causes COVID-19) has led to a need for higher quantities for rapid and reliable detection. BioTeZ react on the increased amount on qRT-PCR probes with a ramp up of the
BioTeZ established a novel surface functionalization kit -the TA-PAS system
The strong interaction between streptavidin and biotin is widely utilized in biotechnological applications (1). The new TAPAS label was developed to extend the portfolio for assay manufactured and will be valuable for its applications across a wide range of biotechnological